|
|
|
UK Focused Ultrasound Foundation Announces Launch
- A new foundation in the UK will fund research and increase awareness to advance focused ultrasound.
- The launch event was held on January 30 to celebrate this important milestone.
- Focused ultrasound treatments for prostate cancer and essential tremor are approved by the National Institute for Health and Care Excellence (NICE) and receive coverage from the National Health Service (NHS) England.
READ THE PRESS RELEASE > |
|
|
|
|
|
Meet the Expert: Professor Wladyslaw Gedroyc
- Prof. Wladyslaw “Wady” Gedroyc, MBBS, MRCP, FRCR, is a consultant radiologist at St. Mary’s Hospital, Imperial College National Health Service Trust.
- For more than 20 years, he has been an integral part of advancing focused ultrasound in the UK.
- Prof. Gedroyc has treated more than 800 patients using the technology.
READ THE PROFILE > |
|
|
|
Consensus Paper Reviews Use of Focused Ultrasound to Help Treat Diffuse Midline Gliomas
- A new consensus paper describes the use of focused ultrasound to help treat diffuse midline gliomas (DMGs).
- The paper provides a comprehensive overview of all related preclinical and clinical studies, most of which use the technology to open the blood-brain barrier (BBB).
- Four manufacturers are currently in clinical trials using their systems to open the BBB to treat DMGs and other brain tumors.
READ MORE > |
|
|
|
|
|
Pitch Your Ultrasound Product Ideas in the UltraCon Shark Tank
- The American Institute of Ultrasound in Medicine’s (AIUM) UltraCon meeting is hosting a shark tank to promote new technologies and product development ideas in medical ultrasound.
- Pitches will be assessed by a panel of experts from industry, venture capital, and academia.
- The deadline to apply is February 21.
READ MORE > |
|
|
|
|
|
Company Profile: Cordance Medical
- Cordance Medical is a startup company headquartered in Mountain View, California.
- The company’s NeuroAccess™ platform is being developed for targeting blood-brain barrier opening.
- We spoke with CEO Ryan Dittamore about Cordance’s origins and future studies.
READ MORE > |
|
|
|
|
|
|
|
OxSonics Clinical Data Demonstrates Device Safety
- Initial clinical data suggests that OxSonics Therapeutics' ultrasound-based drug delivery platform SonoTran® is safe and well-tolerated in patients with metastatic colorectal cancer.
- The data were presented at the recent 28th European Symposium on Ultrasound Contrast Imaging.
- SonoTran is in clinical development to enhance delivery and improve efficacy of oncology drugs, particularly those that struggle to penetrate tumors.
READ THE PRESS RELEASE > |
|
|
|
|
|
|
|
Recent Webinars & Podcasts |
|
Do you have news for our newsletter? Tell us about it!
|
March 1-5, 2023 European Congress of Radiology (ECR) 2023, Vienna, Austria
March 4-9, 2023 Society of Interventional Radiology (SIR) Annual Meeting, Phoenix, AZ
March 19-24, 2023 Winter School on Therapeutic Ultrasound, Les Houches, France
March 25-29, 2023 American Institute for Ultrasound in Medicine (AIUM) Annual Convention 2023, Orlando, Florida | Rebranded as UltraCon
April 14-19, 2023 American Association for Cancer Research (AACR) Annual Meeting 2023, Orlando, Florida
April 16-19, 2023 European Conference on Interventional Oncology (ECIO) 2023, Stockholm, Sweden
April 17-20, 2023 22nd Annual International Symposium on Therapeutic Ultrasound (ISTU) and 6th European Symposium on FUS (EUFUS) Joint Conference, Lyon, France
April 21, 2023 2nd HIFUture Symposium 2023, Lyon, France
April 23-27, 2023 38th Annual Society for Thermal Medicine (STM) Meeting, San Diego, CA
June 22-24, 2023 Society for NeuroOncology’s 7th Biennial Pediatric Neuro-Oncology Research Conference, Washington, DC
June 22-24, 2023 MIB Agents FACTOR Osteosarcoma Conference, Atlanta, GA | Abstracts are due February 24 |